CorMedix Inc.(CRMD)

POST12.200.04+0.33%19:50 EST

12.16+0.53+4.56%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- CorMedix Inc.'s (NASDAQ:CRMD) 28% Jump Shows Its Popularity With Investors
  Simply Wall St. · 2025-12-23
  CorMedix Inc.'s (NASDAQ:CRMD) 28% Jump Shows Its Popularity With Investors
- CorMedix Inc. CEO Joseph Todisco Reports Disposal of Common Shares
  Reuters · 2025-12-20
  CorMedix Inc. CEO Joseph Todisco Reports Disposal of Common Shares
- Is CorMedix Still Attractive After 45% YTD Surge and Strong Cash Flow Outlook?
  Simply Wall St. · 2025-12-19
  Is CorMedix Still Attractive After 45% YTD Surge and Strong Cash Flow Outlook?
- CorMedix Is Maintained at Buy by D. Boral Capital
  Dow Jones · 2025-12-19
  CorMedix Is Maintained at Buy by D. Boral Capital
- BRIEF-Cormedix Reports Positive Data From Real World Study of Defencath
  Reuters · 2025-12-18
  BRIEF-Cormedix Reports Positive Data From Real World Study of Defencath
- CorMedix Reports Positive Interim Results from Real-World DefenCath Study in Hemodialysis Patients
  Reuters · 2025-12-18
  CorMedix Reports Positive Interim Results from Real-World DefenCath Study in Hemodialysis Patients
- CorMedix Director Steven W. Lefkowitz Reports Sale of Common Shares
  Reuters · 2025-12-11
  CorMedix Director Steven W. Lefkowitz Reports Sale of Common Shares
- Assessing CorMedix (CRMD) Valuation Following Recent Share Price Pullback
  Simply Wall St. · 2025-11-23
  Assessing CorMedix (CRMD) Valuation Following Recent Share Price Pullback
- CorMedix price target raised to $18 from $17 at H.C. Wainwright
  TIPRANKS · 2025-11-13
  CorMedix price target raised to $18 from $17 at H.C. Wainwright
- U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare
  Reuters · 2025-11-13
  U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare
- Talphera Raises $17 Million in Private Placement Led by CorMedix
  Reuters · 2025-11-13
  Talphera Raises $17 Million in Private Placement Led by CorMedix
- Talphera Reports Third Quarter 2025 Results and Announces $17 Million Financing
  Reuters · 2025-11-13
  Talphera Reports Third Quarter 2025 Results and Announces $17 Million Financing
- CorMedix Is Maintained at Buy by Needham
  Dow Jones · 2025-11-13
  CorMedix Is Maintained at Buy by Needham
- BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners
  Reuters · 2025-11-12
  BUZZ-U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners
- Stock Track | CorMedix Soars 12.60% on Strong Q3 Results and Raised 2025 Guidance
  Stock Track · 2025-11-12
  Stock Track | CorMedix Soars 12.60% on Strong Q3 Results and Raised 2025 Guidance
- CorMedix Shares Reverse Premarket Course, Last Down 1.3%
  THOMSON REUTERS · 2025-11-12
  CorMedix Shares Reverse Premarket Course, Last Down 1.3%
- BUZZ-U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global
  Reuters · 2025-11-12
  BUZZ-U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global
- UPDATE: Cormedix Q3 Adj. EPS $0.57 Misses $0.65 Estimate. Adj EPS Excludes One-time Tax Benefit $59.7M
  Benzinga · 2025-11-12
  UPDATE: Cormedix Q3 Adj. EPS $0.57 Misses $0.65 Estimate. Adj EPS Excludes One-time Tax Benefit $59.7M
- CorMedix Swings to Q3 Profit, Revenue Rises; Lifts Full-Year Guidance
  MT Newswires Live · 2025-11-12
  CorMedix Swings to Q3 Profit, Revenue Rises; Lifts Full-Year Guidance
- Stock Track | CorMedix Soars 9.47% Pre-Market on Strong Q3 Results and Raised Guidance
  Stock Track · 2025-11-12
  Stock Track | CorMedix Soars 9.47% Pre-Market on Strong Q3 Results and Raised Guidance
Company Profile
Company Name
CorMedix Inc.
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.cormedix.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
- 2025-12-30
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-12-18
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-12-09
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-12-09
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-24
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-14
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-13
  Employee Stock Ownership
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-11-12
  Quarterly Report
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-12
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-11-10
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-11-06
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-10-20
  Major Issues Report
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-09-30
  Major Issues Report
  Form 8-K/A - Current report: [Amend]
  Form 8-K/A - Current report: [Amend]
- 2025-09-12
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-09-12
  Proposed Sale Of Securities
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities

1D
5D
Day
Week
Month

Loading ...

High

12.29

Open

11.81

Volume%

0.98

Low

11.74

11.63

T/O Rate

2.93%

To The Moon

CorMedix Inc.(CRMD)

Company Profile

Most Discussed